Literature DB >> 10404005

New developments in the pathogenesis and treatment of steroid-induced osteoporosis.

S C Manolagas1, R S Weinstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10404005     DOI： 10.1359/jbmr.1999.14.7.1061

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  71 in total

Review 1.  Glucocorticoid-induced osteoporosis.

Authors:  R S Weinstein
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  In vivo NMR microscopy allows short-term serial assessment of multiple skeletal implications of corticosteroid exposure.

Authors:  Masaya Takahashi; Felix W Wehrli; Luna Hilaire; Babette S Zemel; Scott N Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 3.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

Review 4.  [Cortisone therapy today].

Authors:  Hanns Kaiser
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

Review 5.  Musculoskeletal pain associated with corticosteroid therapy in cancer.

Authors:  Deborah A Frieze
Journal:  Curr Pain Headache Rep       Date:  2010-08

6.  Glucocorticoid use and its association with skeletal health among U.S. adults with diabetes.

Authors:  Sarah Stark Casagrande; Catherine C Cowie; Saul Malozowski
Journal:  J Diabetes Complications       Date:  2016-06-27       Impact factor: 2.852

7.  Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Authors:  Philip M Grant; Virginia Sheikh; Rebecca DerSimonian; Adam Rupert; Gregg Roby; Alice Pau; Michael C Sneller; Sheryl-Vi Rico; Todd T Brown; Irini Sereti
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-21       Impact factor: 2.205

8.  Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment.

Authors:  A H van Lierop; A W van der Eerden; N A T Hamdy; A R Hermus; M den Heijer; S E Papapoulos
Journal:  J Clin Endocrinol Metab       Date:  2012-07-27       Impact factor: 5.958

9.  Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.

Authors:  A Papaioannou; W Parkinson; N Ferko; L Probyn; G Ioannidis; E Jurriaans; G Cox; R J Cook; D Kumbhare; J D Adachi
Journal:  Osteoporos Int       Date:  2003-10-09       Impact factor: 4.507

Review 10.  From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis.

Authors:  Stavros C Manolagas
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.